DOCETAXEL IN COMBINATION WITH GEMCITABINE AS SECOND LINE TREATMENT IN PATIENTS WITH PLATINUM RESISTANT ADVANCED NSCLC

被引：0
|
作者：
Gori, B. [1 ]
Longo, F. [1 ]
Zivi, A. [1 ]
De Sanctis, R. [1 ]
Del Signore, E. [1 ]
Proietti, E. [1 ]
Sperduti, I. [2 ]
De Filippis, L. [1 ]
Stumbo, L. [1 ]
Quadrini, S. [1 ]
Di Seri, M. [1 ]
机构：
[1] Policlin Umberto 1, Rome, Italy
[2] Regina Elena Inst Canc Res, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [1] Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC
    Gori, Bruno
    Longo, Flavia
    Zivi, Andrea
    Sperduti, Isabella
    Stumbo, Luciano
    Del Signore, Ester
    De Sanctis, Rita
    Quadrini, Silvia
    De Filippis, Lucilla
    Di Seri, Marisa
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S696 - S696
  • [2] DOCETAXEL-GEMCITABINE AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED GASTRIC CANCER
    D'Alessio, Andrea
    Amato, Maria Grazia
    Resta, Davide
    Sbarufatti, Antonio
    Tacchini, Laura
    Venturi, Cristina
    Visacarra, Cecilia
    ANNALS OF ONCOLOGY, 2009, 20
  • [3] SAFETY OF DOCETAXEL MONOTHERAPY AS SECOND-LINE TREATMENT IN ADVANCED NSCLC ELDERLY PATIENTS
    Song, X.
    Li, P.
    Zhang, G.
    Fu, P.
    Peng, A.
    Tan, M.
    Liu, Y.
    Li, M.
    Li, X.
    Wang, C.
    RESPIROLOGY, 2011, 16 : 173 - 173
  • [4] Gemcitabine in combination with oxaliplatin as second-line therapy of advanced and metastatic NSCLC
    Alencar, A. J.
    Blaya, M.
    Raez, L.
    Farfan, N.
    Lopes, G.
    Walker, G.
    Flores, A.
    Macintyre, J.
    Rocha-Lima, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer
    Carlo Barone
    Michele Basso
    Giovanni Schinzari
    Carmelo Pozzo
    Nunziatina Trigila
    Ettore D'Argento
    Michela Quirino
    Antonio Astone
    Alessandra Cassano
    Gastric Cancer, 2007, 10 : 104 - 111
  • [6] Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer
    Barone, Carlo
    Basso, Michele
    Schinzari, Giovanni
    Pozzo, Carmelo
    Trigila, Nunziatina
    D'Argento, Ettore
    Quirino, Michela
    Astone, Antonio
    Cassano, Alessandra
    GASTRIC CANCER, 2007, 10 (02) : 104 - 111
  • [7] Docetaxel in combination with gemcitabine (DG) versus docetaxel (D) as front-line treatment in patients with advanced/metastatic NSCLC: A multicentre, randomized, phase III trial.
    Georgoulias, V
    Syrigos, K
    Agelidou, M
    Potamianou, A
    Polyzos, A
    Varthalitis, J
    Gerogianni, A
    Ziras, N
    Mavroudis, D
    Androulakis, N
    Samonis, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 633S - 633S
  • [8] Combination of docetaxel and gemcitabine in the treatment of advanced mon-small cell lung cancer (NSCLC)
    Jensen, NV
    Hansen, O
    Rose, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S258 - S258
  • [9] Docetaxel and oxaliplatin combination as second-line treatment in patients with advanced gastric cancer.
    Schinzari, G
    D'Argento, E
    Quirino, M
    Basso, M
    Trigila, N
    Di Leonardo, G
    Cassano, A
    Pozzo, C
    Barone, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 354S - 354S
  • [10] Docetaxel in combination with Gemcitabine as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Barata, Fernando
    Sousa, Amelia
    Camacho, Elvira
    Costa, Marco S.
    Canario, Dolores
    Nogueira, Fernando
    Semedo, Eulalia
    ANNALS OF ONCOLOGY, 2004, 15 : 179 - 179
12345